Sisram Medical Ltd
HKSE: 1696.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Eyal Ben David
- Employees
- 1,000
- Headquarters
- Caesarea, Israel
- IPO year
- 2017
- Market cap
- HK$1.4B
- Website
- https://www.sisram-medical.com
Loading 1696…
Loading profile data…Frequently asked questions about 1696
What does Sisram Medical Ltd (1696.HK) do?
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, in...
Where does 1696.HK trade?
Sisram Medical Ltd (1696.HK) trades on the Hong Kong Stock Exchange.
What sector is 1696.HK in?
Sisram Medical Ltd (1696.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Sisram Medical Ltd?
Eyal Ben David is the chief executive officer of Sisram Medical Ltd (1696.HK).
Where is Sisram Medical Ltd headquartered?
Sisram Medical Ltd is headquartered in Israel.
Does 1696.HK pay a dividend?
Yes — Sisram Medical Ltd (1696.HK) paid a trailing twelve-month dividend of HKD 0.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1696.HK go public?
Sisram Medical Ltd (1696.HK) completed its initial public offering in 2017.